About Celery Pharma
Celery Pharma is a company based in India. Celery Pharma offers products and services including Nitrile Examination Gloves and Sterile Gauze Swab.
- Headquarter India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Celery Pharma Private Limited
- Date of Incorporation 23 Dec, 2019
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.09 Cr
FY 2024 · +3% YoY
- Net Profit₹0.00 Cr
FY 2024 · 0% margin
- EBITDA₹0.00 Cr
FY 2024 · 0% margin
Associated legal entities of Celery Pharma
Celery Pharma operates through Celery Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celery Pharma Private Limited CIN U24297DL2019PTC359185 | Active | 23 Dec 2019 | New Delhi, Delhi | ₹1.1 Cr | – | 2 | View details |
Products & Services of Celery Pharma
Celery Pharma offers a comprehensive portfolio of products and services, including Nitrile Examination Gloves and Sterile Gauze Swab.
Nitrile examination gloves are manufactured for medical, lab, and industrial use, being latex-free, durable, and puncture-resistant to ensure protection and safety.
Sterile gauze swabs are produced from 100% cotton for wound care and surgical applications, providing high absorbency and softness to support effective medical practices.
Board of directors of Celery Pharma Private Limited (Celery Pharma)
Celery Pharma Private Limited is the primary company behind Celery Pharma. The board of Celery Pharma Private Limited currently have 2 directors; the longest-serving is Ajay Kumar, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajay Kumar DIN 08647366 | Managing Director | 23 Dec 2019 | 6 yrs 9 mo | Celery Pharma Private Limited |
| Vikash Kumar DIN 08647367 | Director | 23 Dec 2019 | 6 yrs 9 mo | Celery Pharma Private Limited |
Financials of Celery Pharma
Figures of Celery Pharma Private Limited, the primary company behind Celery Pharma, for FY 2024. Revenue was ₹1.09 Cr (+3% year on year). Net profit was ₹0.00 Cr (0% margin). EBITDA was ₹0.00 Cr (0% margin). Revenue has grown at a compounded annual rate of +11% over three years.
- ₹1.09 CrRevenue · FY 2024 · +3% YoY
- ₹0.00 CrNet profit · 0% margin
- ₹0.00 CrEBITDA · 0% margin
- ₹0.01 CrPaid-up capital
- +11%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Celery Pharma Private Limited are on its company page.
Detailed financial statements for Celery Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Celery Pharma
10 companies that operate in the same segment as Celery Pharma (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 12.68 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.32 B | – | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celery Pharma
Celery Pharma is headquartered in India.
The primary company behind Celery Pharma, Celery Pharma Private Limited, reported revenue of ₹1.09 Cr for FY 2024, up 3% year on year.
Celery Pharma Private Limited is recognized as a leading manufacturer of surgical gloves and medical disposables, with products such as examination gloves, gauze swabs, and surgical aprons being produced to meet global standards. Quality control systems are upheld to ensure compliance and reliability, while innovation is emphasized in operations. The company serves a diverse network of healthcare clients worldwide, focusing on safety and precision in every product. Trust is built through certified processes and a commitment to excellence in the medical field.
Celery Pharma offers Nitrile Examination Gloves and Sterile Gauze Swab.
Celery Pharma operates through Celery Pharma Private Limited.
The legal entities of Celery Pharma currently have 2 directors, including Ajay Kumar, Vikash Kumar.